Nasopharyngeal Diseases  >>  zoledronic acid  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
zoledronic acid / Generic mfg.
NCT00697619: To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer

Completed
3
60
RoW
Zometa (zoledronic acid), Zometa
Sun Yat-sen University, Novartis
Nasopharyngeal Cancer
01/09
09/09

Download Options